Arca
Skip to content
Tools
Tools

End stage renal disease

Drug research and approvals for end stage renal disease: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 168 studies of end stage renal disease are recruiting on ClinicalTrials.gov, Health Canada has authorized 9 drug trials for it since 2013, and FDA has 3 approved and 13 open orphan designations naming it.

  • Recruiting worldwide: 168
  • Trials authorized in Canada: 9
  • FDA orphan approvals: 3
  • EU medicines: 0

Recruiting now

Newest posted first, of 168 recruiting on ClinicalTrials.gov ↗

How its trials ended

1,934 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 398 whose ending is known, 42% met their primary endpoint, 8% missed it and 50% stopped early.

  • Completed, result not reported98351%
  • Status unknown29315%
  • Ongoing26013%
  • Met its primary endpoint1679%
  • Stopped: other or unclear1146%
  • Stopped: enrollment or feasibility462%
  • Missed its primary endpoint312%
  • Stopped: sponsor or business decision151%
  • Stopped: funding131%
  • Stopped: lack of efficacy101%
  • Stopped: safety2<1%

Trials authorized in Canada

Newest first; search them all in Canada trials
May 30, 2025Effect of canagliflozin on ultrafiltration & fibrosis in patients on peritoneal dialysis (can-pd trial)CanagliflozinResearch Institute of The McGill University Health CentrePending
Jun 12, 2024Evaluation of thiosulfate in end stage renal disease and kidney transplantationSodium thiosulfateLondon Health Sciences CentreOngoing
Apr 5, 2023The efficacy, mechanism & safety of sodium glucose co-transporter-2 inhibitor & glucagon-like peptide 1 receptor agonist combination therapy in kidney…Dapagliflozin/ SemaglutideUniversity Health NetworkOngoing
Jan 4, 2023Mechanisms and safety of SGLT2 inhibition in peritoneal dialysis - the canary studyEmpagliflozinUniversity Health NetworkPending
Jun 15, 2022A randomized parallel-group, placebo-controlled, double-blind, event-driven, multi-center phase 2 clinical outcome trial of prevention of arteriovenous graft…MK-2060Merck & Co. (MSD)Ongoing
Apr 10, 2017Aldosterone blockade for health improvement evaluation in end-stage renal disease (ACHIEVE)SpironolactonePopulation Health Research InstituteClosed
Feb 19, 2016Pharmacokinetics and pharmacodynamics of apixaban in end-stage renal disease patients on hemodialysisApixabanJewish General HospitalClosed
Aug 11, 2015A phase 2, randomized, double blind, placebo controlled study of the safety, pharmacokinetics, and pharmacodynamics of multiple doses of isis 416858…Isis 416858Ionis PharmaceuticalsClosed
May 30, 2014A pilot study to evaluate the feasibility and safety of performing a double blind, placebo-controlled, randomized controlled trial of the routine use of ssri's…EscitalopramUniversity Health NetworkOngoing

FDA orphan designations

Approved first, then open designations, newest first; 15 of 16
Dec 20, 2002Extraneal (with 7.5% Icodextrin) Peritoneal Dialysis SolutioFor use as a single daily exchange for the long (8-16 hour) dwell during continuous ambulatory peritoneal dialysis (CAPD) or automated…Baxter Healthcare CorporationApproved
Dec 15, 1999CarnitorPrevention and treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis.Leadiant Biosciences, Inc.Approved
Jun 1, 1989EpogenTreatment of anemia associated with chronic renal failure, including patients on dialysis (end stage renal disesae) and patients not on…Amgen, Inc.Approved
Nov 9, 2020Peritoneal dialysis solution containing combination of…Treatment of patients with end stage renal disease who are undergoing peritoneal dialysisCoreQuest SaglDesignated
Mar 7, 2019TecarfarinPrevention of systemic thromboembolism of cardiac origin in patients with End Stage Renal Disease and atrial fibrillationCadrenal Therapeutics, Inc.Designated
Feb 21, 2019Peritoneal dialysis solution containing combination of…Treatment of patients with end stage renal disease who require peritoneal dialysisCoreQuest SaglDesignated
Nov 6, 2017Alanyl-glutamine dipeptidePrevention of complications associated with peritoneal dialysis (PD) treatment in end stage renal disease (ESRD)Zytoprotec GmbHDesignated
Jun 15, 2017Human monoclonal antibody against phosphorylcholinePrevention of arteriovenous fistula or arteriovenous graft failure in patients with end stage renal disease receiving hemodialysis or…Athera Biotechnologies, ABDesignated
May 10, 2012Sirolimus in an implantable collagen matrixPrevention of arteriovenous(AV) fistula or AV graft failure in patients with end stage renal disease, receiving hemodialysis or preparing…SiraNex Bio, LLCDesignated
Jun 6, 1990Calcium carbonateTreatment of hyperphosphatemia in patients with end stage renal disease.R & D Laboratories, Inc.Designated
Jun 27, 1989Calcium acetateTreatment of hyperphosphatemia in end stage renal disease.Pharmedic CompanyDesignated
Nov 19, 1987Erythropoietin (human, recombinant)Treatment of anemia associated with end stage renal disease.Organon Teknika CorporationDesignated
Oct 22, 1987Epoetin betaTreatment of anemia associated with end stage renal disease.Chugai-USA, Inc.Designated
Aug 27, 1987Epoetin alphaTreatment of anemia associated with end stage renal disease.R. W. Johnson Pharmaceutical Research InstituteDesignated
Aug 19, 1987Erythropoietin (recombinant human)Treatment of anemia associated with end stage renal disease.McDonnell Douglas CorpDesignated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.